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Background: Candida albicans yeast produces 10 distinct secreted aspartic proteases (Saps), which are some of the
most important virulence factors of this pathogenic fungus. One of the suggested roles of Saps is their deregulating
effect on various proteolytic cascades that constitute the major homeostatic systems in human hosts, including blood
coagulation, fibrinolysis, and kallikrein-kinin systems. This study compared the characteristics of the action of all 10 Saps
on human kininogens, which results in generating proinflammatory bradykinin-related peptides (kinins).
Results: Recombinant forms of Saps, heterologously overexpressed in Pichia pastoris were applied. Except for Sap7 and
Sap10, all Saps effectively cleaved the kininogens, with the highest hydrolytic activity toward the low-molecular-mass
form (LK). Sap1–6 and 8 produced a biologically active kinin—Met-Lys-bradykinin—and Sap3 was exceptional in terms
of the kinin-releasing yield (>60% LK at pH 5.0 after 24 hours). Des-Arg1-bradykinin was released from LK by Sap9 at a
comparably high yield, but this peptide was assumed to be biologically inactive because it was unable to interact with
cellular B2-type kinin receptors. However, the collaborative actions of Sap9 and Sap1, −2, −4–6, and −8 on LK rerouted
kininogen cleavage toward the high-yield release of the biologically active Met-Lys-bradykinin.
Conclusions: Our present results, together with the available data on the expression of individual SAP genes in candidal
infection models, suggest a biological potential of Saps to produce kinins at the infection foci. The kinin release during
candidiasis can involve predominant and complementary contributions of two different Sap3- and Sap9-dependent
mechanisms.
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The secretion of active proteases is one of the most suc-
cessful strategies used by microbial pathogens to colonize
and infect human hosts [1]. By hydrolyzing proteinaceous
targets in the host organism, including the proteins in cell
membranes and extracellular matrix, these enzymes allow
the pathogen to penetrate tissues and acquire nutrients.
These enzymes also play important roles in evading the
immune system by cleaving immune regulatory proteins
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unless otherwise stated.host that require cascade-activated proteolysis such as the
blood coagulation [3], fibrinolysis [4], complement [5],
and kallikrein-kinin system [6].
Candida albicans is one of the most common fungal
pathogens in humans [7]. This yeast-like fungus can re-
lease as many as 10 aspartic class proteases into the
extracellular space [8]. C. albicans is part of the physio-
logic human microbiota, but, under some circumstances
that are generally related to immune system weaknesses in
the host, it can convert to a dangerous pathogen that causes
diseases of variable severity. These candidiases can range
from relatively mild and easily curable superficial infections
of the skin and mucous membranes to life-threatening
deep-seated invasions in the inner organs, fungemia, andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 HPLC/MS characteristics of the Sap-catalyzed cleavage
of the HK-D4 peptide. Ten μM of the synthetic peptide HK-D4 (which
has the ISLMKRPPGFSPFRSSRIGEIKEET amino acid sequence) were treated
with recombinant Sap1–10 in citrate (50 mM) or phosphate buffers
(25 mM) at the optimal pH for the general proteolytic activity [26] of
each individual Sap (specified in the figure) at an enzyme:substrate molar
ratio of 1:50 for 24 hours at 37°C. The reaction was stopped using HCl,
and the samples were analyzed using reversed-phase HPLC on an Eurosil
Bioselect 300–5 C-18 column (Knauer) in a TFA-water-ACN binary gradient
system. The fractions, which were collected at the major absorbance peaks
(215 nm), were evaporated and analyzed using ESI-MS/MS in order to
determine their amino acid sequence.
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that the number and diversity of secreted aspartic proteases
(Saps) from C. albicans are needed to successfully colonize
the variety of niches present in humans [10], but this hy-
pothesis is still unsatisfactorily evidenced by experimental
data. In particular, relatively few studies are devoted to sys-
tematically comparing the actions of all 10 Saps on a single
proteinaceous substrate.
Bradykinin-related peptides, which are collectively called
kinins, are proteolytically released from the serum proteins,
kininogens [11-13]. Serine proteases, called kallikreins are
primarily devoted to this task [14], but during pathological
states, including those associated with microbial infections,
other proteases, either from the host or the pathogen,
can supplement the actions of the kallikreins [15-18]. Due
to the multiple functions of kinins required to regulate
various physiological processes, as well as their participa-
tion in almost every inflammatory state [11,12,19], the
kallikrein-kinin system is considered a major system re-
quired for biochemical homeostasis in humans. Overac-
tivated kinin production reportedly occurs in infections
caused by numerous bacterial species [6,20]. Regarding
candidal infections, Kaminishi et al. [21] was the first to
report that a purified major extracellular protease of C.
albicans possesses kinin-releasing potential, albeit in-
directly, based on the activation of an upstream-acting
zymogen in the kinin-generating cascade (factor XII).
The direct release of kinins from kininogens was later con-
firmed for mixtures of proteases that were released into
the culture medium by several Candida species [22] and
the purified C. albicans protease, which was unequivocally
identified as Sap2 [23]. Sap2 is believed to be the predom-
inant protease secreted by C. albicans when cultured in
protein-rich media, but the SAP gene expression profile
depends on the fungal morphology, and the high expres-
sion of different SAP genes has been reported in various in-
fection models [24,25].
This study compares the characteristics of kininogen
cleavage and concomitant kinin release due to all 10 in-
dividual Saps, used in recombinant purified forms. Here,
we report the exceptionally high kinin-forming activity
of Sap3. Moreover, the active kinins are produced with a
high yield by mixtures of Sap9 and several other Saps.
Results
The mechanism responsible for the Sap-catalyzed cleavage
of domain 4 of human kininogen was studied using a syn-
thetic peptide—denoted as HK-D4—because its amino acid
sequence (ISLMKRPPGFSPFRSSRIGEIKEET) can be ob-
tained from the kinin-containing region of the kininogen
molecule. The cleaved products were separated using
high performance liquid chromatography (HPLC), and
the major peaks were collected and analyzed to determine
their sequences using tandem mass spectrometry (MS/MS).Comparative chromatograms of the samples, obtained after
incubating HK-D4 with all individual recombinant Saps for
long periods of time (i.e., 24 hours) at the optimal pH for
general proteolytic activity (against standard proteinaceous
substrates such as casein) [26] are shown in Figure 1. HK-
D4 was effectively cleaved by all Saps, except Sap7 and
Sap10. The qualitative distributions of the major formed
products are similar for Sap1–6 and 8; however, Sap3 dem-
onstrated the ability to release a kinin-like peptide—Met-
Lys-bradykinin (MKRPPGFSPFR)—at the highest yield
(approximately 50%). Moderate-to-small amounts of the
same peptide were also detected among the minor prod-
ucts of HK-D4 that were cleaved by Sap2, which agrees
with our recent characterization of the kininogenase activ-
ity of the natural, purified Sap2 [23] and Sap1, Sap4, and
Sap8. In contrast, Sap9 showed a higher preference to
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ginine residues than Sap3, and thus could easily cleave the
bond between the arginine and proline located at the N-
terminal side of the internal bradykinin sequence. Due to
this exceptional specificity, the HK-D4 cleavage pattern
caused by Sap9 was unique, and a different, kinin-related
peptide—des-Arg1-bradykinin (PPGFSPFR)—was formed
at a high yield (approximately 80%).
The dependence of the kinin yield on the pH for all
kinin-forming Saps (i.e., Sap1-4 and 8–9, see Figure 1) is il-
lustrated in Figure 2. Only Sap3 presented the optimal
kinin-forming activity at pH markedly shifted from the
optimum with the general protease substrates (pH 3 in this
case) towards a more neutral pH. Thus, > 70% of HK-D4
was cleaved by Sap3 towards Met-Lys-bradykinin produc-
tion at pH 5. Importantly, kinin release was still detectable
at ≥ pH 6.Figure 2 Effect of pH on Sap-catalyzed kinin release from the HK-D4
50 mM citrate buffers (pH 3.0–5.0) or 25 mM phosphate buffers (pH 6.0–7.0) f
samples were analyzed using HPLC as specified in Figure 1. The amounts of M
estimated based on the peak areas and are expressed relative to the maximum
Data represent mean values from the analysis of three independent samples (thThe time course of HK-D4 cleavage by the Saps reveals
the order by which particular peptide bonds are preferably
cleaved (Figure 3). The cleavage preferences of Sap1
(Figure 3), Sap2, Sap4, and Sap8 (data not shown) are es-
sentially the same as that previously reported for natural,
purified Sap2 [23]. The bonds after Lys22 and Leu3 were
hydrolyzed at the highest rates. Thus, the N-terminus of
the kinin to be formed (Met-Lys-bradykinin) was estab-
lished during the very early stages of Sap-catalyzed HK-
D4 hydrolysis (within the first hour) and persisted on a
longer time scale. A number of additional cleavages oc-
curred downstream from the kinin C-terminus, which
ended up with the exposition of Ser16, and usually Ser15
although at a slower rate. Thus, the MKRPPGFSPFRSS
and MKRPPGFSPFRS peptides could be considered the
major final products of HK-D4 cleavage following treat-
ment with this set of Saps. Hydrolyzing the bond afterpeptide. HK-D4 (10 μM) was cleaved using 0.2 μM Saps (1–4, 8, and 9) in
or 24 hours at 37°C. The reaction was stopped using HCl (0.33 M), and the
et-Lys-bradykinin or des-Arg1-bradykinin (for Sap9) that formed were
possible amount (calculated using the molarity of the reaction substrate).
ree separate digests) ± the standard deviation.
Figure 3 Time course of HK-D4 cleavage by Sap1, Sap3, Sap5, and Sap6. HK-D4 (10 μM) was cleaved using 0.2 μM Sap in 50 mM citrate
buffer (pH 5.0) at 37°C for the specified time. The reaction was stopped using HCl, and the samples were analyzed using HPLC as specified in
Figure 1. The results from representative kinetic experiments are shown. The areas under the peaks of the early, major cleavage products, as well
as the kinin-related peptides, are expressed relative to the substrate at the beginning of the reaction.
Kozik et al. BMC Microbiology  (2015) 15:60 Page 4 of 14Arg14, which completes the formation of Met-Lys-
bradykinin, occurred at very slow rates when treated with
Sap2, −4, −1, and −8 (in that order in terms of kinin yield).
Due to the high preference of Sap3 for hydrolyzing the
bonds after Arg14 and Arg17 (Figure 3), Met-Lys-bradykinin
was one of the major end products of HK-D4 cleavage, to-
gether with the MKRPPGFSPFRSS and MKRPPGFSPFRSSR
peptides.
The cleavage of HK-D4 by Sap5 and Sap6 (Figure 3) was
limited to the hydrolysis of the two bonds after Lys22 and
Leu3. Sap5 quickly cleaved the bond after Lys22 to form
the ISLMKRPPGFSPFRSSRIGEIK peptide, at the expense
of which the MKRPPGFSPFRSSRIGEIK peptide appeared
after a longer period of time at a much lower rate. These
two cleavages alternatively occurred at high and com-
parable rates due to the action of Sap6, which lead to
the fast formation of the ISLMKRPPGFSPFRSSRIGEIK
and MKRPPGFSPFRSSRIGEIKEET peptides that there-
after were quickly converted to the final major product,
MKRPPGFSPFRSSRIGEIK. Among other very minor prod-
ucts that resulted from the actions of Sap5 and Sap6 on
HK-D4, no kinin-like peptides were found using the applied
chromatographic method (although they could be visual-
ized using MS; see below). The unique time course of HK-
D4 cleavage by Sap9 (data not shown) was characterized by
the very fast formation of des-Arg1-bradykinin, which wasonly preceded by quickly disappearing precursors such as
the ISLMKRPPGFSPFR or PPGFSPFRSSRIG peptides.
An analysis using sodium-dodecyl-sulphate polyacryl-
amide-gel electrophoresis (SDS-PAGE) showed that Sap1–
6, −8, and −9 cleaved native human kininogens, with a high
preference for the low-molecular-mass form (LK) in com-
parison with the high-molecular-mass form (HK) (data not
shown). Using the optimized HPLC method, the clearly
distinguishable peak of Met-Lys-bradykinin was visible on
the chromatograms obtained after LK digestion by Sap1–4
and −8, while Sap9 resulted in the intense peak of des-Arg1-
bradykinin (Figure 4). To identify all kinin-like peptides
formed by all individual Saps (even those formed in very
small amounts), the more sensitive liquid chromatography-
coupled tandem mass spectrometry (LC-MS/MS) method
was applied. We found that (1) in addition to Sap1–4
and −8, Sap5 and Sap6 also exhibited kinin-forming activ-
ities toward the LK substrate and (2) each individual Sap
produced multiple kinin-like peptides (Table 1). These in-
cluded, in addition to the predominant Met-Lys-bradykinin
(or des-Arg1-bradykinin for Sap9), bradykinin itself, and (1)
occasional traces of kinin derivatives without the C-terminal
Arg residues (Sap1, Sap2, Sap4, Sap8, Sap9), (2) Leu-Met-
Lys-bradykinin (Sap2, Sap3, Sap9), and (3) versions of kinins
with hydroxyproline (POH) at the third position of the
bradykinin sequence, as could have been expected from
Figure 4 HPLC profiles of the fragmentation of LK by selected Saps. LK samples (1.5 μM) were digested with 0.03 μM of Sap1, −3, −4, −8, and −9
in the citrate buffer (pH 5.0) at 37°C for 24 hours. The reaction was stopped using pepstatin A (10 μM), followed by acidification with HCl
(0.33 M). The samples were analyzed using HPLC on the Luna C18(2) 5 μm 4.6 × 250 mm column (Phenomenex) in a TFA water-ACN binary
gradient system, as described in the Materials and Methods section. Arrows indicate the retention times of the Met-Lys-bradykinin (M) and
des-Arg1-bradykinin (D) standards.
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or both (all Saps except Sap5).
The relative distributions of the main kinins were quan-
titatively determined in the Sap-treated LK samples using
the HPLC analysis, collecting fractions at the retention
times for bradykinin, Met-Lys-bradykinin, and des-Arg1-
bradykinin, and enzyme-linked immunosorbent assay
(ELISA) for kinins in these fractions (Figure 5). While de-
tectable, small amounts of bradykinin were released from
LK by all studied Saps, Sap9 produced this “main” kinin at
the relatively highest yield, which approached 2% of the
maximum releasable kinin content in the sample. All
tested Saps produced Met-Lys-bradykinin at the yield,
which decreased in the order of Sap3 > > Sap1 ≈ Sap8 >
Sap2 ≈ Sap4 > > Sap5 ≈ Sap6 ≈ Sap9; however, no Sap
could favorably compete with Sap3 over the long term
(i.e., 24 hours) in terms of the kinin release yield (>60%
LK). At a comparably high yield, Sap9 could produce des-
Arg1-bradykinin that would barely be detectable in the LK
digests obtained after long incubation with other Saps.
The Sap-treated LK samples were additionally analyzed
for their interactions with HEK293 cells, which were engi-
neered to overexpress B2-subtype kinin receptors on the
surface (Figure 6). This part of our study aimed to assess pu-
tative biological activity, typical of kinins, in the peptide mix-
tures generated by Saps from human kininogen. Using this
type of ligand-receptor radioassay [28], the highest amount
of “bradykinin equivalents” was found in the LK digests ob-
tained using Sap3, followed by those generated by Sap9.
Interpreting these results was not straightforward because
attempts to calibrate the radioassay with synthetic des-Arg1-
bradykinin failed to detect any interactions between thispeptide and the B2 receptors (results not shown), contrary
to Met-Lys-bradykinin which binds to receptors although at
a 10-fold lower affinity than bradykinin [23,29]. Thus, the
peak of B2 receptor-binding activity, which was found in
the Sap9-treated LK samples (Figure 6), was probably due to
the bradykinin that developed in the largest amount in com-
parison with all other Saps (Figure 5). The highest peak re-
corded for Sap3 was obviously due to the large amount of
the true B2-receptor agonist (Met-Lys-bradykinin) produced
from LK by this protease at a nearly stoichiometric yield
(Figure 5). Actually, the apparent amount of kinin in this
sample was underestimated by the radioassay, which had
been calibrated to the bradykinin standard.
The short peptide—des-Arg1-bradykinin (PPGFSPFR)—
was assumed to be biologically inactive because of its in-
ability to interact with B2 receptors. Therefore, we were
very interested to determine if Sap9 can hydrolyze the pep-
tide bond after the third arginine residue in (1) Met-Lys-
bradykinin, thereby inactivating this biologically active kinin
formed from the kininogens by the other Saps, and (2)
other peptides with an N-terminal Met residue, such as
MKRPPGFSPFRSSRIGEIK, MKRPPGFSPFRSS, MKRPPGF-
SPFRS, and MKRPPGFSPFRSSR—which are the fast-
appearing major products of kininogen cleavage by other
Saps—thereby preventing the subsequent conversion to
active kinin. Surprisingly, as shown in Figure 7, Sap9 was
essentially unable to process these substrates at the N-
terminus, suggesting that this protease requires a long
stretch of amino acids upstream from the N-terminal side of
the internal bradykinin sequence (≥6 residues) to effect-
ively cleave the N-terminal bond between the Arg and
Pro residues. However, the C-terminal arginine residue of
Table 1 Kinin-like peptides in the Sap-treated LK samples
that were identified using LC-MS/MS
Sap Kinin-like peptide Molecular mass (Da)
Sap1 MKRPPGFSPFR 1318.8
MKRP(POH)GFSPFR 1334.7
(MO)KRPPGFSPFR 1334.7
MKRPPGFSPF 1162.8
RPPGFSPFR 1059.8
PPGFSPFR 903.4
Sap2 MKRPPGFSPFR 1318.8
MKRP(POH)GFSPFR 1334.7
(MO)KRPPGFSPFR 1334.7
RPPGFSPFR 1059.8
LMKRPPGFSPFR 1431.9
MKRPPGFSPF 1162.8
RP(POH)GFSPF 919.7
Sap3 MKRPPGFSPFR 1318.7
MKRP(POH)GFSPFR 1334.7
(MO)KRPPGFSPFR 1334.7
(MO)KRP(POH)PGFSPFR 1350.7
RPPGFSPFR 1059.8
LMKRPPGFSPFR 1432.0
LMKRP(POH)GFSPFR 1447.8
L(MO)KRPGFSPFR 1447.8
Sap4 MKRPPGFSPFR 1318.7
MKRP(POH)GFSPFR 1334.7
(MO)KRPPGFSPFR 1334.7
(MO)KRP(POH)PGFSPFR 1350.7
RPPGFSPFR 1059.8
RP(POH)GFSPF 919.7
Sap5 MKRPPGFSPFR 1318.8
RPPGFSPFR 1059.8
Sap6 MKRPPGFSPFR 1318.8
RPPGFSPFR 1059.8
MKRP(POH)GFSPFR 1334.7
Sap8 MKRPPGFSPFR 1318.7
MKRP(POH)GFSPFR 1334.7
(MO)KRPPGFSPFR 1334.7
(MO)KRP(POH)PGFSPFR 1350.7
RPPGFSPFR 1059.8
MKRPPGFSPF 1162.8
Sap9 MKRPPGFSPFR 1318.9
RPPGFSPFR 1059.6
PPGFSPFR 903.5
P(POH)GFSPFR 919.5
LMKRPPGFSPFR 1432.0
Table 1 Kinin-like peptides in the Sap-treated LK samples
that were identified using LC-MS/MS (Continued)
LMKRP(POH)GFSPFR 1447.8
PPGFSPF 747.4
LK samples (1.5 μM) were digested with 0.03 μM Sap in citrate buffer (pH 5.0)
at 37°C for 24 hours. The reaction was stopped using pepstatin A (at a final
concentration of 10 μM), and the samples were acidified with HCl (0.33 M) and
subjected to LC-MS/MS analysis using the Bruker HCTultra ETDII IT mass
spectrometer that was equipped with an ESI ion source and ETD II fragmentation
module and was coupled to the Dionex Ultimate 3000 UHPLC system. MS/MS
data were analyzed using in-house Mascot server (version 2.3.0), and the peptides
were identified by searching the Swiss-Prot database. The peptides marked in
bold generated peaks with the highest intensities (> 105 arbitrary units), which
exceeded by≥ 1 order of magnitude in comparison with the other peptides.
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actions between the free kinins and B2 receptors—was still
quickly exposed by Sap9. Thus, the Sap-catalyzed cleavage
of all substrates with N-terminal methionine converged to
a single product, Met-Lys-bradykinin, (i.e., an active kinin).
The unique specificity of Sap9, as determined by our
analysis of the synthetic peptides, allows mixtures of Sap9
and Sap1, −2, −4–6, and −8 to demonstrate the strikingly
enhanced formation of Met-Lys-bradykinin from kinino-
gen in comparison with the individual actions of these
proteases (Figure 8). At the same time, the production of
the biologically inactive peptide, des-Arg1-bradykinin, was
largely quenched. This effect was particularly dramatic
with Sap5 and Sap6, which individually produced only
trace amounts of Met-Lys-bradykinin, but in the presence
of Sap9 the kinin yield exceeded even that of the best indi-
vidual kinin producer, Sap3. In contrast, the release of
Met-Lys-bradykinin from Sap3 was not enhanced in the
presence of Sap9, apparently because both these proteases
cleave the bond after the Arg residue on the C-side of the
internal kinin sequence at a comparably high rate. How-
ever, the production of des-Arg1-bradykinin by the Sap3
and Sap9 mixture was quenched by about half in compari-
son with the amount released from the kininogen using
Sap9 alone.
Discussion
The success of C. albicans as a pathogen is due to its ability
to inhabit various niches within the host organism, includ-
ing the skin, oral and vaginal mucosa, gastrointestinal tract,
and, as in systemic infections, all inner organs and the
blood [9,30,31]. This yeast-like fungus can adapt to different
environments due to the development of an impressive array
of virulence factors [32], including yeast-to-hyphae transi-
tion, morphologic switches, numerous surface-exposed
adhesins, and hydrolytic enzymes such as Saps. The multi-
plicity of the effects that determine candidal infections
makes it difficult to reliably dissect the relative role of a
single factor in the colonization and invasion of host
tissues. Thus, eliminating a single virulence factor—e.g.,
gene mutations—often unsatisfactorily reduces the strain
Figure 5 Distribution of bradykinin, Met-Lys-bradykinin, and
des-Arg1-bradykinin in the Sap-digested LK samples. LK samples
(1.5 μM) were digested using 0.03 μM Sap in the citrate buffer (pH 5.0)
at 37°C for 6 hours. After sequentially stopping the reaction using
pepstatin A and HCl, the obtained peptide mixtures were separated on
the Luna C18 column in a TFA water-ACN binary gradient system. The
fractions were collected at the retention times that correspond to the
bradykinin, Met-Lys-bradykinin, and des-Arg1-bradykinin standards,
evaporated to dryness, and redissolved in the assay buffer of the ELISA
kit in order to quantitatively determine the kinin concentrations. The
corresponding fractions, obtained from the HPLC separation of intact
(undigested) LK served as the controls, and the kinin concentrations,
determined in these fractions are subtracted from those in the
Sap-digested LK samples. The corrected amount of each of the
three kinins is expressed relative to the maximum possible amount
of all kinins (as calculated using the molarity of LK in the sample).
Results, obtained from two independent experiments (two LK-digests
independently analyzed by HPLC for each Sap), with three replicate
ELISA measurements (in three different wells) for each fraction obtained
during each HPLC separation, are presented as the mean values ±
standard deviation. Asterisks denote the statistical significance of
the difference between the kinin levels in the Sap-treated and
undigested LK samples (t-Student test, p < 0.05). The data plotted
in the three panels are for bradykinin (A), Met-Lys-bradykinin
(B), and des-Arg1-bradykinin (C).
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factors [25,33]. Regarding the 10 different Saps of C. albi-
cans, functional redundancy must also exist because nu-
merous attempts to assign specific roles to individual Saps
have not led to a general consensus [25,34]. Extensive stud-
ies on the expression of individual SAP genes in various
in vitro and in vivo models of candidal infections report
contradictory results [35,36].
Regarding the role in microbial infections, the kinin-
forming system can be compared to a double-edged sword
[6]. Primarily, the proinflammatory and vasoactive properties
of kinins contribute to the refined multifactorial process that
provides host defenses against pathogens. For instance, ki-
nins recruit defense cells such as neutrophils and monocytes
to the infection foci [37] and activate many cell types in
order to release other, even more potent proinflammatory
mediators [38]. However, at least one activity of kinins—en-
hancing vascular permeability—is beneficial to pathogens,
helping them acquire the necessary nutrients from serum
and disseminate within the host organism [17]. The upregu-
lation of kinin production has been frequently reported in
association with bacterial infections [6,20]. Relatively re-
cently, the hijacking of the kinin-forming system of the host
was suggested to occur as part of fungal infections such as
candidiasis. In vitro studies show that, similar to bacterial
pathogens, C. albicans can mimic two mechanisms of kinin
production used by the host to defeat infections, although in
an uncontrolled manner. One mechanism depends on the
adsorption of HK and the other components of the contact
system on the fungal cell wall [39-41], which resembles the
Figure 6 The amounts of the B2 receptor-interacting peptides
in the Sap-digested LK samples. LK samples (1.5 μM) were digested
with 0.03 μM Sap in the citrate buffer (pH 5.0) at 37°C for 6 or 24 hours,
the reaction was stopped using pepstatin A (at a final concentration of
10 μM), and the samples were analyzed for kinin content using a
competitive radioreceptor assay that used B2 receptor-overexpressing
HEK293 cells. The calibration plot for the assay was prepared using a
bradykinin standard. The results are corrected by subtracting the values,
determined in the undigested LK sample. Data represent mean values
from three separate radioreceptor binding analyses (three independently
prepared cultures of B2 receptor-bearing cells), with the measurements
performed in triplicates within each experiment. The error bars represent
the standard deviations; asterisks denote the statistical significance of the
differences between Sap-treated and undigested LK samples (t-Student
test, p < 0.05).
Figure 7 Time course of the cleavage of the MKRPPGFSPFRSSR
peptide using Sap9. MKRPPGFSPFRSSR peptide (5 μM) was cleaved
using 0.1 μM Sap9 in 50 mM citrate buffer (pH 5.0) at 37°C for the
specified time. The reaction was stopped using HCl, and the sample
was analyzed using HPLC as specified in Figure 1. The results from a
representative kinetic experiment are shown. The areas under the
peaks of separated peptides are expressed relative to the substrate
at the beginning of the reaction.
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ous host cells [42-45]. The second mechanism involves Saps
that activate factor XII [21] or directly release kinins from ki-
ninogens [22,23].
In the current study, for the first time, we compared
the kininogenase activities of all 10 Saps. Eight of these,
Sap1–8, are soluble secreted proteins, while Sap9 and
Sap10 are bound to the cell wall via a glycosylphosphati-
dylinositol (GPI) anchor, although some fraction of these
proteins can be shed into the extracellular space [8]. We
found that all soluble Saps (except Sap7) can release
kinins from human kininogens and strongly prefer LK to
HK as the substrate. In each case, the same kinin—Met-
Lys-bradykinin—was formed almost exclusively, i.e., in ex-
cess over the other identified kinin-like peptides, including
bradykinin. Despite its relatively low affinity for B2-type
kinin receptors [23,29], Met-Lys-bradykinin is equivalent
to bradykinin and kallidin (Lys-bradykinin) in terms of
biological activity [46], most likely because it can be easily
converted to the latter “main” kinins in biological fluids
and tissues that are abundant with nonspecific aminopep-
tidases [29]. The current, unequivocal identification of the
chemical nature of the formed kinin peptides—together
with the findings that the unfractionated peptide mixtures
generated by Sap1-6 and Sap8 from LK interact with B2
receptors (Figure 6)—provides strong support for the
hypothesis that these soluble Saps can release biologic-
ally active kinins at infection sites, as they are likely to
encounter the appropriate amounts of kininogens to be
cleaved [47,48]. The qualitatively uniform picture ob-
served for all individual soluble Saps suggests a high
degree of redundancy between these Saps with respect
to the postulated kinin-forming functions.
Quantitatively, however, the kininogenase activity of
Sap3 so strongly exceeded those of the other Saps that it
should be considered the predominant player in putative
Sap-dependent kinin production at the sites of candidal
infections. At sufficient Sap3 levels, Sap1–2, Sap4–6, and
Sap8 would only comprise a fungal proteolytic reserve for
kininogen cleavage. However, their significance would in-
crease in the rather unlikely case of Sap3 being absent at
the infection site, not only due to their ability to generate
a small but persistent stream of kinins but also the quick
release of peptides with extended C-terminal sequences
(in comparison with receptor B2-interacting kinins). These
peptides have occasionally been reported to exert bio-
logical effects that are typical of kinins in animal models
[16], but this is most likely due to additional processing by
tissue carboxypeptidases.
Of the two Saps that bind to the fungal cell wall via the
GPI anchor, Sap10 was unable to cleave the kininogens at
all; in contrast, Sap9 rapidly and nearly completely excised
from LK des-Arg1-bradykinin (PPGFSPFR) that is assumed
to be biologically inactive because it does not interact with
Figure 8 Comparisons of the generation of bradykinin, Met-Lys-bradykinin, and des-Arg1-bradykinin in LK samples that were digested
using a mixture of Sap9 and other Saps vs digestion with single Saps. LK samples (1.5 μM) were digested with either 0.03 μM individual Saps
or mixtures of 0.03 μM Sap9 with equimolar amounts of other Saps in the citrate buffer (pH 5.0) at 37°C for 6 hours. After sequentially stopping the
reaction with pepstatin A and HCl, the obtained peptide mixtures were separated on the Luna C18 column in a TFA water-ACN binary gradient system.
Fractions were collected at the retention times that correspond to the bradykinin (B), Met-Lys-bradykinin (M), and des-Arg1-bradykinin standards (D),
evaporated to dryness, and redissolved in the assay buffer of the ELISA kit in order to quantitatively determine the kinin concentrations. The results are
corrected by subtracting the data, obtained for the undigested LK sample as specified in Figure 5. The amount of each of the three kinins is expressed
relative to the maximum possible amount of all kinins (calculated using the molarity of LK in the sample). For each Sap, the light gray bar represents
the sum of kinin amounts in two independent samples, treated separately with this Sap and Sap9 while the dark gray bar represents the value for
sample of LK that was treated with a mixture of this Sap and Sap9. All data bars represent the mean values of six determinations (averaged as
specified in Figure 5) ± standard deviation. Asterisks denote the statistical significance (t-Student test, p < 0.05) of the difference between the
indicated kinin levels (generated by a mixture of Sap9 and other Sap vs digestion with two Saps separately).
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without the C-terminal arginine—i.e., des-Arg1,9-bradyki-
nin (PPGFSPF)—that can potentially form in host tissues
due to the actions of carboxypeptidases, is not a high-
affinity ligand of B1 receptors (data not shown). However,
a specific Sap9-dependent inactivation of the kininogens at
the fungal cell wall is unlikely in the light of the previous
findings that in virtually any infection model in which
SAP9 gene expression is detected, some soluble Saps are
also produced [25,49].
The impressive adaptability of C. albicans to very different
environments within the host organism depends on the
compatibility of various virulence factors, such as Saps, with
the broad range of environmental parameters. pH is one of
the most important parameters to consider [26]. Indeed, the
optimal pH for the enzymatic activity of the 10 C. albicans
Saps ranges between 2–7, which is sufficiently broad to as-
sure that ≥ 1 Sap will effectively hydrolyze proteinaceous tar-
gets in each of the major niches that are colonized and
infected by this fungus, including the skin (pH 4.7–7), va-
gina (pH 4), oral cavity (pH 6.3–6.8), blood (pH 7.4), and
different parts of the gastrointestinal tract (pH 2–8). Of the
two Saps that are hypothesized to play critical roles in kinin
generation at the sites of candidal infections, Sap3 optimally
acts at an acidic pH. However, this Sap is exceptional among
all Saps, not only because of its high kinin-releasing activity
against LK, but also because the optimal pH for this process
markedly shifts toward neutral relative to general proteolytic
activity; therefore, remarkable kinin production can be ex-
pected even at pH > 6. Sap9 optimally cleaved LK at pH 5.5
but, again, the pH optimum of this activity is relatively
broad. A number of soluble Saps that exhibit optimal kini-
nogenase activity at a pH as low as 3 (Sap8) and as high as
6 (Sap4) could potentially collaborate with Sap9. Thus, the
extensive generation of active kinins from kininogens can
potentially occur in most C. albicans-infected host niches.
The findings of our current study need to be discussed
in the light of previous reports on the actual presence of
individual Saps at infection foci. By applying multiple infec-
tion models and different methodologies, the available data
are both diverse and controversial. Moreover, most studies
primarily focus on the expression of Sap-encoding mRNA
[50,51] and only occasionally quantify protein products
using western blot analysis [52], but these studies do not
reveal anything about the in situ proteolytic activities of in-
dividual Saps. However, the hypothesis that soluble Sap3
alone, or membrane-bound Sap9 with the assistance of
several soluble Saps, controls kinins at the sites of candidal
infections seems to be relatively insensitive to the discrep-
ancies in the literature because it is difficult to find any
studies that definitely exclude the expression of both SAP3
and SAP9 from any infection model. This subject has been
extensively reviewed [25,35], but only a few representative
findings can be cited here. In a study by Albrecht et al.[53], the high, constitutive expression of the SAP9 gene
was consistently detected in both reconstituted human epi-
thelium (RHE) models and human patient samples. Naglik
et al. [8,51] reported the common expression of the SAP2,
SAP5, SAP9 and SAP10 genes in C. albicans isolates ob-
tained from the oral cavity and vagina in human patients.
SAP gene expression profiles, as well as their order of ap-
pearance during infection, differ between oral and vaginal
candidiases. For instance, SAP1, SAP3, and SAP8 are more
commonly expressed in vaginal rather than oral infections
in humans [25,35]. In a study on the oral RHE model,
SAP1 and SAP3 were initially expressed, followed by SAP6,
and finally SAP2 and SAP8 during the late phase of infec-
tion [50]; in the vaginal RHE model, the initial expression
of the SAP2, SAP10, and SAP9 genes was followed by the
appearance of the SAP1, SAP4 and SAP5 transcripts, and fi-
nally the expression of SAP6 and SAP7 [49]. In both oral
and vaginal RHE infected by sap-deficient mutants, Sap1–3
were found to play predominant roles in mucosal tissue
damage during the initial phase of the infection [49,50].
The results obtained in various animal models are more di-
verse, but some studies report the expression of all SAP
genes in murine gastrointestinal infection [54] or the strong,
sustained expression of SAP5 and SAP9 in murine oropha-
ryngeal candidiasis [55].
Conclusions
The abilities of most of the 10 C. albicans Saps to cleave
human kininogen and release kinins, and the available
literature on SAP gene expression during candidal infec-
tions strongly support the hypothesis that kinins are ef-
fectively produced at the infection foci during many
types of candidiasis and contribute to the inflammatory
state of this disease in humans. While small or moderate
levels of kinins can be generated by all Saps (except Sap7
and Sap10), the highest level of kinin production depends
on the actions of soluble Sap3 or the combined actions of
cell wall-bound Sap9 and other soluble Saps such as Sap1,
Sap2, Sap4, Sap5, Sap6, and Sap8. The relative contribu-
tions of these two mechanisms to potentially generate
kinin at infection foci seem to depend on both the type
and phase of infection.
Methods
Expression and purification of recombinant Saps
The 10 Sap isoenzymes were overproduced in P. pastoris
GS115 (Invitrogen, Carlsbad, CA) using previously described
methods with minor modifications [26]. However, in-
stead of affinity chromatography, final purification consisted
of anion-exchange chromatography performed on a Mono
Q HR 10/10 column (GE Healthcare, Buckinghamshire, UK)
that was equilibrated with 20 mM Tris–HCl (pH 7.5) and
eluted using a 0–0.3 M NaCl linear gradient. The proteolytic
activity of the purified isozymes was assayed on the BODIPY
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been adjusted to the optimum pH for each respective Sap
(i.e., citrate [pH 3.0–5.0] or phosphate [pH 6.0–7.0]) [26].
Substrate cleavage was monitored using fluorometric mea-
surements at 485-nm excitation and 530-nm emission wave-
lengths. The protein concentration was determined using
the Bradford method [56]. Sap purity was analyzed using
SDS-PAGE in the Laemmli system [57], and was determined
to be > 95% for each Sap. The identities of all Saps were con-
firmed using LC-MS/MS after SDS-PAGE and in-gel trypsin
digestion [58]. Briefly, the protein bands, which were visual-
ized using colloidal staining with Coomassie Brilliant Blue
dye [59], were excised from the gel and washed twice with
50 mM (NH4)HCO3 in 50% acetonitrile (ACN) (HPLC
gradient-grade; Merck, Darmstadt, Germany) at both
room temperature and 37°C in order to remove any dye,
and then reduced using 10 mM dithiothreitol (DTT) for
60 minutes at 60°C, alkylated with 55 mM iodoacetamide
for 45 minutes at room temperature in the dark, washed
with 100 mM (NH4)HCO3, and dehydrated with ACN.
After re-swelling on ice in the digestion buffer, which con-
tained 12.5 ng/μL of sequence-grade modified trypsin
(Promega, Madison, WI), 50 mM (NH4)HCO3, and 4 mM
CaCl2, the gel pieces were incubated overnight at 37°C.
Acidic peptides were extracted by adding 50 mM (NH4)
HCO3 and basic peptides with 5% formic acid in 50%
ACN. The supernatants were then combined, diluted with
water, and subjected to LC-MS/MS analysis (see below).
HPLC and MS/MS analysis of the Sap-catalyzed cleavage
of HK-D4
The synthetic peptide HK-D4 (Lipopharm, Zblewo,
Poland), which contains the ISLMKRPPGFSPFRSSRI-
GEIKEETT sequence (10 μM), was incubated with the
individual Saps at a substrate:enzyme molar ratio of
50:1 in 50 mM citrate buffer or 25 mM phosphate buf-
fer at 37°C. The buffer pH and incubation time are the
experimental variables, and are further specified in the
Results section. The reaction was stopped by mixing
the sample (100 μL) with 20 μL of 2 M HCl, and the
obtained peptides were separated on a Eurosil Bioselect
300–5 C-18 reversed-phase HPLC column (5 μm, 4 ×
250 mm) equipped with a pre-column (both from
Knauer, Berlin, Germany). The flow rate was 1 mL/mi-
nute, and spectrophotometric detection was performed
at 215 nm. Separation was performed using a two-
solvent system (solvent A consisted of 0.1% trifluoroa-
cetic acid [TFA] in water; solvent B consisted of 0.08%
TFA in 80% ACN), with a linear gradient of 10–30%
solvent B for 50 minutes using a Shimadzu LC-10A
VP HPLC system (Kyoto, Japan) (two model LC-10 AD
VP pumps, SIL-10 AD VP auto injector, SPD-10A VP
UV–vis detector, SCL-10A VP system controller and
CLASS-VP ver. 5.032 software). For MS/MS identification,the peptide fractions were collected, evaporated to dryness,
redissolved in 30% methanol (Merck, Darmstadt, Germany)
containing 0.1% formic acid (Sigma-Aldrich), and injected
into the ion source of the mass spectrometer (see below for
additional details).
Analysis of Sap-catalyzed LK cleavage
LK (1.5 μM; Sigma-Aldrich) was digested with 0.03 μM Sap
in citrate buffer (pH 5.0) for 6 or 24 hours at 37°C. The re-
action was stopped using pepstatin A (at a final concentra-
tion of 10 μM), and the samples were (1) analyzed for kinin
content using a competitive radioreceptor assay, (2) acid-
ified with HCl (to a final concentration of 0.33 M) and sub-
jected to LC-MS/MS analysis (see below), or (3) acidified
with HCl and subjected to HPLC separation using
Shimadzu chromatograph (as specified above) on the
Luna C18(2) column (5 μm, 4.6 × 250 mm) (Phenom-
enex, Torrance, CA) in the binary gradient formed be-
tween 0.1% TFA in water (solvent A) and 0.08% TFA in
80% ACN (solvent B). Separation was performed ac-
cording to the following time program: 20–29% solvent
B in 45 minutes, and 29–100% solvent B in 10 minutes.
The fractions were separately collected at the retention
times that corresponded to the bradykinin, Met-Lys-
bradykinin, and des-Arg1-bradykinin standards, evapo-
rated to dryness, and redissolved in the assay buffer
provided with the ELISA kit in order to quantitatively
determine the kinin concentration (see below).
LC-MS/MS
The equipment used for the LC-MS/MS analysis consisted
of an HCTultra ion-trap (IT) mass spectrometer equipped
with an electrospray ionization (ESI) ion source and elec-
tron transfer dissociation (ETD II) fragmentation module
(Bruker, Bremen, Germany), which were coupled to the
ultrahigh-performance liquid chromatography (UHPLC)
Dionex Ultimate 3000 system (Thermo Scientific, Waltham,
MA). An Accucore C-18 column (2.6 μm, 2.1 × 100 mm;
Thermo Scientific) was used to separate peptides in a binary
gradient of 10-25% solvent B in 38 minutes, at a flow
rate of 0.2 mL/minute (solvent A consisted of 0.1%
spectrophotometric-grade formic acid [Sigma-Aldrich]
in LC-MS grade water; solvent B consisted of 0.1% formic
acid in 80% ACN). The LC separation step was omitted
for some analyses, and the samples were directly injected
using a syringe pump (KD Scientific, Holliston, MA) at a
flow rate of 180 μL/hour. All mass spectrometric mea-
surements were performed in positive ion mode with a
capillary voltage of 3.5 kV, a nebulizing gas (nitrogen) pres-
sure of 10 psi, drying gas (nitrogen) flow of 5 L/minute,
and dry gas temperature of 300°C. Spectra were acquired
in MS/MS mode in the range of 100–3000 m/z with ETD
ion fragmentation. Tandem MS data analysis was per-
formed using DataAnalysis™ 4.0 and Biotools™ 3.2 software
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searching the Swiss-Prot database using in-house Mascot
server (ver. 2.3.0; Matrix Science, London, UK).
Competitive radioreceptor assay for evaluating kinins
HEK293 cells that stably overexpressed the kinin B2 recep-
tors were obtained using the Flp-In T-Rex-System (Invitro-
gen), as previously described [60]. Cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) with a high-
glucose concentration, 2 mM glutamine, and sodium pyru-
vate (CytoGen GmbH, Sinn, Germany) and supplemented
with 10% fetal bovine serum (FBS) (Lonza, Switzerland),
0.1 mg/mL penicillin/streptomycin (CytoGen GmbH), and
250 ng/mL amphotericin B (CytoGen GmbH). Medium
was replaced every 3–4 days, and cells were routinely sub-
cultured with trypsin-EDTA (CytoGen GmbH) for detach-
ment and transfer. For all experiments, cells (5 × 104) were
transferred to the wells of 96-well plates that had been pre-
treated with 0.01% polylysine (Sigma-Aldrich) in phosphate-
buffered saline (PBS) (CytoGen GmbH) and cultured to
80–100% confluence.
The radioreceptor assay was performed according to a
previously described method [28]. Before all experiments,
the cell monolayers were washed three times with cold PBS
and incubated for half an hour in the equilibration buffer
(40 mM PIPES, 100 mM NaCl, 5 mM KCl, 0.1% glucose,
0.05% bovine serum albumin [BSA], 2 mM CaCl2, and
1 mM Mg2Cl2 [pH 7.4]) that had been supplemented with
peptidase inhibitors (80 μM 1,10-phenantroline [Sigma-
Aldrich], 100 μM captopril [Fluka, Buchs, Switzerland], and
2 mM bacitracin [Sigma-Aldrich]). After removing the buf-
fer, the cells were incubated on ice with a mixture of 2 nM
[3H]-bradykinin (Perkin-Elmer, Waltham, MA) and brady-
kinin, Met-Lys-bradykinin, or des-Arg1-bradykinin. The
concentrations of the unlabelled peptides in the mixtures
varied between 0.05 nM–50 μM. After 90 minutes, the cells
were washed four times with PBS and incubated with
200 μL of 0.2 M acetate buffer with 0.5 M NaCl (pH 2.7).
The supernatants with the dissociated [3H]-labeled tracer
peptides were transferred to vials containing 2.5 mL of
Ultima Gold™ scintillation fluid (Perkin-Elmer), and radio-
activity was measured using a beta counter (Wallace 1412;
LKB, Uppsala, Sweden).
Kinin determination using ELISA
The kinin concentration was determined using the
Bradykinin-EIA kit (Peninsula Laboratories/Bachem,
San Carlos, CA) according to the manufacturer’s instruc-
tions. In this assay, the kinin in each sample competes with
a fixed concentration of biotinylated bradykinin to bind
with the antiserum that is immobilized to the microplate
well. The concentration of bound biotinylated tracer was
determined using streptavidin-conjugated horseradish per-
oxidase/3,3′,5,5′-tetramethylbenzidine (SA-HRP/TMB), andthe kinin content of the sample was estimated from the
calibration curve prepared for the kinin concentration
range (0–5 nM). Because the antibody used in this assay
was specific to the 5 amino acid C-terminal sequence of
bradykinin, identical calibration plots were obtained using
bradykinin, Met-Lys-bradykinin, and des-Arg1-bradykinin.
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